JE Gerich - Archives of Internal Medicine, 2003 - archinte.highwire.org It is well established that strict glycemic control (hemoglobin A 1c <7.0%) can
prevent the microvascular complications of diabetes mellitus. Recent studies
indicate that elevated plasma glucose concentrations are an independent and ... Cited by 134 - Related articles - BL Direct - All 5 versions
RJ Heine, JM Dekker - Diabetologia, 2002 - Springer Type II (non-insulin-dependent) diabetes mellitus is a very prevalent chronic
disease occurring in 2 to 4% of the general population in the Western world and
up to 20 to 30% in high risk populations [1]. Moreover, the global burden ... Cited by 129 - Related articles - BL Direct - All 5 versions
A Dornhorst - The Lancet, 2001 - Elsevier The loss of early-phase insulin secretion is an important and early event in the
natural history of type 2 diabetes. Because a normal pattern of insulin
secretion is essential for the effective control of postprandial ... Cited by 105 - Related articles - BL Direct - All 5 versions
- ►aspetjournals.org ME Doyle, JM Egan - Pharmacological reviews, 2003 - ASPET Blood glucose levels are sensed and controlled by the release of hormones from
the islets of Langerhans in the pancreas. The -cell, the insulin-secreting cell
in the islet, can detect subtle increases in circulating glucose levels and ... Cited by 79 - Related articles - BL Direct - All 8 versions
- ►endojournals.org K Maedler, RD Carr, D Bosco, RA Zuellig, T … - Journal of Clinical Endocrinology & Metabolism, 2005 - Endocrine Soc Loss of ß-cell mass and function raises a concern regarding the application of
sulfonylureas for the treatment of type 2 diabetes because previous studies have
shown that agents that cause closure of inwardly rectifying K + ... Cited by 77 - Related articles - All 6 versions
L Van Gaal, I De Leeuw - Diabetologia, 2003 - Springer Pharmacological therapy for Type 2 (non-insulin-de- pendent) diabetes mellitus
aims at controlling hyper- glycaemia to delay or prevent complications associat-
ed with the disease. Most patients with Type 2 diabe- tes present with both ... Cited by 50 - Related articles - BL Direct - All 4 versions
PC Deedwania, VA Fonseca - The American journal of medicine, 2005 - Elsevier As the prevalence of diabetes continues to increase worldwide, diabetes-related
macrovascular morbidity and mortality are becoming major health care problems.
Epidemiologic evidence suggests this relationship begins early in the ... Cited by 48 - Related articles - All 14 versions
M Marre, L Van Gaal, KH Usadel, M Ball, I … - Diabetes Obesity and Metabolism, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 44 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org C Saloranta, C Guitard, E Pecher, P de Pablos … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—This multicenter, double-blind, randomized,
parallel-group, fixed-dose study of 8 weeks' duration was performed in a total
of 288 subjects with IGT using a 2:2:2:1 randomization. Subjects received ... Cited by 34 - Related articles - BL Direct - All 11 versions
